Virologist discusses decision to offer under-30s alternative vaccine to Oxford/AstraZeneca jab

Virologist discusses decision to offer under-30s alternative vaccine to Oxford/AstraZeneca jab

Assessment

Interactive Video

Social Studies, Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The video discusses the risk versus benefit analysis of the AstraZeneca vaccine, focusing on age-related risks and the rarity of blood clots. It highlights the importance of age group considerations in vaccine distribution and reports on the impact of COVID variants globally. The video addresses vaccine skepticism and misinformation, urging individuals to consider the broader context and personal actions to mitigate COVID risks. It compares the risk of blood clots from the vaccine to those from COVID, emphasizing the importance of understanding these risks in decision-making.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the primary reason for using age groups in the distribution of the AstraZeneca vaccine?

Age groups are easier to manage logistically.

Age groups determine the risk of COVID-19 complications.

Age groups are more susceptible to side effects.

Age groups have shown higher vaccine efficacy.

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why might younger populations in the UK be considered for vaccination with AstraZeneca in the future?

They are more likely to travel internationally.

They are currently the most affected by COVID-19.

They have shown a higher rate of vaccine acceptance.

Their risk from COVID-19 may increase with new variants.

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is a significant factor contributing to public skepticism about vaccines?

Lack of vaccine availability.

High cost of vaccines.

Long waiting times for vaccination.

Mixed messages from healthcare professionals.

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the estimated risk of developing blood clots from the AstraZeneca vaccine compared to COVID-19?

1 in 500,000 for the vaccine, 0.5% for COVID-19

1 in 1,000 for the vaccine, 10% for COVID-19

1 in 100,000 for the vaccine, 1 to 2% for COVID-19

1 in 10,000 for the vaccine, 5% for COVID-19

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the recommended approach to help end the COVID-19 pandemic?

Wait for herd immunity to develop naturally.

Combine vaccination with preventive measures.

Focus only on social distancing.

Rely solely on vaccines.